借势创新药BD潮,抗体界“台积电”大器已成

医药魔方
Aug 11

↑↑↑ 长按或扫码,报名参会 ↑↑↑BD潮起,通过授权交易“出海”,无疑是当下中国创新药产业发展最主流,也最具价值想象空间的叙事。一方面,医药巨头们已进入史上最依赖外部创新的时代,前所未有地分享创新红利;另一方面,在资本寒冬下寻求出路的中国创新药,以极强的韧性和灵活性快速切入其中,仅三年就已成为势头最猛的新锐力量。据医药魔方《中国创新药交易十年全景透视》,近十年,全球医药交易以8%的年复合增长率...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10